Literature DB >> 12204572

Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability.

Hanne Hjorth Tønnesen1, Már Másson, Thorsteinn Loftsson.   

Abstract

Cyclodextrin complexes of the natural compound curcumin were prepared in order to improve the water solubility and the hydrolytic and photochemical stability of the compound. Complex formation resulted in an increase in water solubility at pH 5 by a factor of at least 10(4). The hydrolytic stability of curcumin under alkaline conditions was strongly improved by complex formation, while the photodecomposition rate was increased compared to a curcumin solution in organic solvents. The cavity size and the charge and bulkiness of the cyclodextrin side-chains influenced the stability constant for complexation and the degradation rate of the curcumin molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204572     DOI: 10.1016/s0378-5173(02)00323-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  77 in total

1.  Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury.

Authors:  Madathilparambil V Suresh; Matthew C Wagner; Gus R Rosania; Kathleen A Stringer; Kyoung Ah Min; Linda Risler; Danny D Shen; George E Georges; Aravind T Reddy; Jaakko Parkkinen; Raju C Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

2.  Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of curcumin--"a technical note".

Authors:  Neeta Gupta; Nidhi Aggarwal
Journal:  AAPS PharmSciTech       Date:  2008-07-04       Impact factor: 3.246

3.  Drug targeting to the hair follicles: a cyclodextrin-based drug delivery.

Authors:  Fífa Konrádsdóttir; Helga Ogmundsdóttir; Valgardur Sigurdsson; Thorsteinn Loftsson
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

4.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

5.  Photoclick Hydrogels Prepared from Functionalized Cyclodextrin and Poly(ethylene glycol) for Drug Delivery and in Situ Cell Encapsulation.

Authors:  Han Shih; Chien-Chi Lin
Journal:  Biomacromolecules       Date:  2015-06-03       Impact factor: 6.988

6.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

7.  Comparative oral bioavailability advantage from curcumin formulations.

Authors:  Bhushan Munjal; Yogesh Bapurao Pawar; Sarsvatkumar Babulal Patel; Arvind Kumar Bansal
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

8.  Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.

Authors:  Kwok Kin Cheng; Chin Fung Yeung; Shuk Wai Ho; Shing Fung Chow; Albert H L Chow; Larry Baum
Journal:  AAPS J       Date:  2012-12-11       Impact factor: 4.009

Review 9.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

10.  Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.

Authors:  Ece Gülçür; Mentor Thaqi; Fatima Khaja; Antonina Kuzmis; Hayat Önyüksel
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.